EUCTR2014-003671-30-ES进行中（未招募）1 期
Therapeutic effect of propranolol in a series of patients with von Hippel-Lindau disease and retinal hemangioblastomas in short, medium and long term treatment.
ALIANZA ESPAÑOLA DE FAMILIAS DE VON HIPPEL-LINDA0 个研究点开始时间: 2014年9月22日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •PATIENTS DIAGNOSED OF VON HIPPEL-LINDAU DISEASE AND RETINAL HEMANGIOBLASTOMAS, THAT IN ADDITION:
- •- AT LEAST ONE PAPILLARY OR JUXTAPAPILLARY HB, OR
- •- PERIPHERICAL HB, WHO HAD REJECTED ANOTHER TREATMENTS
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 1
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 9
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •CONTRAINDICATIONS TO TAKE PROPRANOLOL
研究者
相似试验
进行中（未招募）
不适用
PROPRANOLOL IN BURNT ADULT PATIENTSBURNT-INDUCED SINUSAL TACHYCARDIAEUCTR2014-001380-13-ESAbelardo Garcia De Lorenzo / Teresa Nuñez-Villaveiran
招募中
3 期
The role of propranolol with L-carnitine in the prophylactic treatment of cyclic vomiting syndromeIRCT20120716010297N9Esfahan University of Medical Sciences104
进行中（未招募）
不适用
Safety and efficacy of treatment with propranolol in newborns suffering from rethinopathy of the preterm: a pilot study - Propranolol and ROPRetinopathy of the pretermMedDRA version: 9.1Level: HLGTClassification code 10047060EUCTR2010-018737-21-ITAZIENDA OSPEDALIERA MEYER
已完成
不适用
Clinical study of oral propranolol treatment for pediatric hemangioma and lymphangiomapediatric hemangioma and lymphangiomaJPRN-UMIN000004453Gifu University Graduate School of Medicine50
招募中
3 期
Investigating the efficacy of oral propranolol in prevention of severe Retinopathy of PrematurityRetinopathy of prematurityIRCT20101018004961N12Kermanshah University of Medical Sciences50